Asthma is a chronic inflammatory disease of the airways, mediated by leukotrienes and other lipid mediators. The condition, which is known as a chronic respiratory disease because it cannot be cured and lasts a lifetime, and its frequent attacks and associated difficulties with breating can be a total drag for those diagnosed.
There are a number of treatments, inhalers being among the most common, that can reduce the frequency and severity of asthma attacks. And now, thanks to a groundbreaking new study, a beneficial new player has been welcomed to the sphere of treatments — New Zealand Green Lipped Mussel Oil.
Particular extracts of the mussel oil have been reported to reduce asthma symptoms and daytime wheezing. These extracts also improve breathing in people with asthma — a huge relief that can be realized in a daily supplement that takes two seconds to ingest.
These research studies have also confirmed that the same extract of New Zealand green-lipped mussel minimizes the amount of rescue medication required by patients with persistent asthma.
How Green-Lipped Mussels Help Asthma Patients
Acute asthma attacks are caused by either physical exercise or by allergens. Inflammatory molecules known as leukotrienes are one of major substances produced by mast cells during an attack of asthma. So, it is the leukotrienes that are primarily responsible for inducing the wheezing and difficulty breathing — bronchoconstriction, to get all scientific.
These chemicals play a major role in allergic rhinitis, allergies, and asthma, also causing a tightening of your airways, making it extremely difficult to breathe.
Leukotrienes induce bronchoconstriction, stimulate mucus secretion, elevate microvascular permeability and trigger infiltration of inflammatory cells like neutrophils and eosinophils into the airways. Asthmatics who have exercise-induced bronchoconstriction (EIB), have elevated levels of LTs in their airways, and responded to anti-LT treatments during chronic therapy.
Treating Asthma with Lipid Extract of New Zealand Green-lipped Mussels
Research studies have shown that lipid extract of New Zealand green-lipped mussel, known as Perna canaliculus, is very effective in inhibiting the primary source of the wheezing and breathing difficulties. These potent pro-inflammatory leukotrienes make it much more difficult for asthma patients to breathe when symptoms are triggered — such as by allergens or other irritators — and the impacts are counteracted by the lipid extract found in mussel supplements such as GLX3.
Asthma is a chronic inflammatory disease of the airways, mediated by leukotrienes and other lipid mediators. The condition, which is known as a chronic respiratory disease because it cannot be cured and lasts a lifetime, and its frequent attacks and associated difficulties with breating can be a total drag for those diagnosed.
There are a number of treatments, inhalers being among the most common, that can reduce the frequency and severity of asthma attacks. And now, thanks to a groundbreaking new study, a beneficial new player has been welcomed to the sphere of treatments — New Zealand Green Lipped Mussel Oil.
Particular extracts of the mussel oil, Lyprinol and Pharmalink specifically, have been reported to reduce asthma symptoms and daytime wheezing. These extracts also improve breathing in people with asthma — a huge relief that can be realized in a daily green-lipped mussel supplement that takes two seconds to ingest.
These research studies have also confirmed that the same extract of New Zealand green-lipped mussel minimizes the amount of rescue medication required by patients with persistent asthma.
